HONG KONG, SHANGHAI and FLORHAM PARK, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the New Drug Application (“NDA”) ...

Over half of these pipelines target non-solid tumors (such as multiple myeloma and various ... Tarlatamab (brand name IMDELLTRA), which targets small cell lung cancer has achieved FDA accelerated ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...